Quarterly report · Q3
6960.TEDINET S100Q3IX
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥93.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥93.1bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥16.1bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥15.9bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.3bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.9bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.8bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥11.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥195.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥195.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥183.2bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.6bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥45.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥156.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥149.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥145.2bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥63.3bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥64.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥383.71 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥115.28 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥536.19 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥382.89 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥135.08 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥25.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥25.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥40.5bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥40.5bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.9bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥20.0bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.0bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥93.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥93.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥16.1bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥24.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥24.5bn |
| jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥8.5bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥18.8bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥18.8bn |
| jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥93.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥93.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥15.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 372
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)櫻井 紀彰 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)梶原 崇宏 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 93068000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 93481000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 132098000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 16320000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 16766000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 23422000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 11579000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 11606000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 16216000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 11773000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 11950000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 16432000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 145197000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 156556000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 149857000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 183202000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 195205000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 195495000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 382.89 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 383.71 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 536.19 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.793 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.802 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.767 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 135.08 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 115.28 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 39176000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 39176000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 39176000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 39176000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 4347500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 15229200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 152292 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 11300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 19588000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 152292 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 4347500 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |